CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...
Phase 3
Salisbury, North Carolina, United States and 17 other locations
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...
Phase 3
Monroe, North Carolina, United States of America and 217 other locations
Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19....
Phase 2
Shelby, North Carolina, United States and 20 other locations
This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI--...
Phase 2
Denver, North Carolina, United States and 54 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Charlotte, North Carolina, United States and 214 other locations
The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...
Phase 3
Monroe, North Carolina, United States of America and 157 other locations
The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effective and safe in adults with COVID-19 who do not need t...
Phase 3
Rock Hill, South Carolina, United States and 263 other locations
This is a Phase 2/3, randomized, double-blind study to evaluate the safety and immunogenicity of different booster dose levels of the monovalent seve...
Phase 2, Phase 3
Gaffney, South Carolina, United States and 49 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Charlotte, North Carolina, United States and 114 other locations
The study is divided into 2 parts: Part 1 and Part 2. The purpose of Part 1 of this study is to generate sufficient safety, reactogenicity, and immun...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 68 other locations
Clinical trials
Research sites
Resources
Legal